The DOI matches its OpenAlex record.
Long-term acyclovir suppression of frequently recurring genital herpes simplex virus infection. A multicenter double-blind trial
Abstract
Normal adults with six or more episodes of genital herpes in the previous year were enrolled in a one-year, multicenter, double-blind trial comparing placebo with 400 mg of acyclovir administered orally twice daily. Patients with episodes during the study were offered 200 mg of acyclovir administered orally five times daily for five days; this allowed comparison of suppressive and episodic treatment. After one year, 227 (44%) of 519 patients receiving suppressive treatment and seven (2%) of 431 receiving placebo (episodic) treatment remained free of recurrences, and the mean numbers of recurrences per year were 1.8 and 11.4, respectively. Among 67 patients who had received suppressive therapy for one year, the mean duration of lesions in the first episode following the discontinuation of treatment was 9.3 days compared with 7.3 days among 45 patients who had received episodic therapy for one year. Treatment was well tolerated, and no changes were noted in the in vitro susceptibility to acyclovir of herpes simplex virus cultured during or after the one-year trial. Continuous or episodic oral acyclovir therapy for one year remained safe and effective.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Whitley, R. J., Kimberlin, D. W., & Roizman, B. (1998) · Clinical Infectious Diseases · doi:10.1086/514600 · Cited by 1,149
Whitley, R. J., & Roizman, B. (2002) · Wiley Encyclopedia of Molecular Medicine · doi:10.1002/0471203076.emm0597 · Cited by 700
Risk Factors for the Sexual Transmission of Genital Herpes
Mertz, G. J., Benedetti, J., Ashley, R., Selke, S. A., & Corey, L. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-116-3-197 · Cited by 475
Self-citationCelum, C., Wald, A., Hughes, J., Sanchez, J., Reid, S., Delany-Moretlwe, S., Cowan, F., Casapia, M., Ortiz, A., Fuchs, J., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60920-4 · Cited by 449
Wood, A. J. J., Whitley, R. J., & Gnann, J. W. (1992) · New England Journal of Medicine · doi:10.1056/nejm199209103271108 · Cited by 410
Acyclovir for the Prevention of Recurrent Herpes Simplex Virus Eye Disease
Wilhelmus, K. R., Beck, R. W., Moke, P. S., Dawson, C. R., Barron, B. A., Jones, D. B., Kaufman, H. E., Kurinij, N., Stulting, R. D., Sugar, J., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199807303390503 · Cited by 391
Wagstaff, A. J., Faulds, D., & Goa, K. L. (1994) · Drugs · doi:10.2165/00003495-199447010-00009 · Cited by 386
A Controlled Trial of Ganciclovir to Prevent Cytomegalovirus Disease after Heart Transplantation
Merigan, T. C., Renlund, D. G., Keay, S., Bristow, M. R., Starnes, V., O'Connell, J. B., Resta, S., Dunn, D., Gamberg, P., Ratkovec, R. M., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199204303261803 · Cited by 376
OʼBrien, J. J., & Campoli-Richards, D. M. (1989) · Drugs · doi:10.2165/00003495-198937030-00002 · Cited by 363
Reitano, M., Tyring, S., Lang, W., Thoming, C., Worm, A. ‐., Borelli, S., Chambers, L. O., Robinson, J. M., Corey, L., & the International Valaciclovir HSV Study Group (1998) · The Journal of Infectious Diseases · doi:10.1086/515385 · Cited by 209
Diaz-Mitoma, F. (1998) · JAMA · doi:10.1001/jama.280.10.887 · Cited by 147
Mertz, G. J. (1997) · Archives of Internal Medicine · doi:10.1001/archinte.1997.00440240109016 · Cited by 121
Self-citation
Metadata
- Authors
- Mertz, G.
- Venue
- JAMA
- Publisher
- American Medical Association
- Published
- 1988-07-08
- Volume
- 260
- Issue
- 2
- Pages
- 201-206
- ISSN
- 0002-9955 (ISSN-L)
- OpenAlex
- W4235830486
- Cited by
- 178
- References
- 0
- FWCI
- 8.70
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.